09.05.2017 Views

Encyclopedia of Health and Medicine

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

276 The Nervous System<br />

• shuffling, hunched posture when walking<br />

(Parkinsonian gait)<br />

• loss <strong>of</strong> balance, especially when changing direction<br />

during walking<br />

Other symptoms develop as the condition progresses<br />

<strong>and</strong> may include SIALORRHEA (excessive<br />

drooling), HYPERHIDROSIS (excessive sweating), BLE-<br />

PHAROSPASM, <strong>and</strong> difficulty speaking <strong>and</strong> swallowing.<br />

There is no definitive diagnostic test for<br />

Parkinson’s disease, so the diagnostic path considers<br />

both personal health history <strong>and</strong> clinical findings.<br />

The neurologist may conduct imaging<br />

procedures such as COMPUTED TOMOGRAPHY (CT)<br />

SCAN <strong>and</strong> MAGNETIC RESONANCE IMAGING (MRI) to rule<br />

out other causes <strong>of</strong> the symptoms, such as BRAIN<br />

TUMOR or STROKE.<br />

Treatment Options <strong>and</strong> Outlook<br />

Treatment targets the symptoms. Some medications<br />

replace dopamine or function as dopamine<br />

agonists to activate dopamine receptors. The<br />

antiviral medication amantadine improves symptoms<br />

in some people. Response to medications is<br />

highly individual. The neurologist chooses medication<br />

combinations according to the person’s<br />

age, general health status, apparent rate <strong>of</strong> progression,<br />

<strong>and</strong> other factors. Most people take combinations<br />

<strong>of</strong> medications to address different<br />

aspects <strong>of</strong> the condition <strong>and</strong> to <strong>of</strong>fset the side<br />

effects <strong>of</strong> some medications. The person eventually<br />

becomes resistant to levodopa, a dopamine<br />

precursor that currently is the only dopaminereplacement<br />

DRUG available. A person who has<br />

Parkinson’s disease can typically take levodopa for<br />

five to seven years.<br />

The US Food <strong>and</strong> Drug Administration (FDA)<br />

recently approved the surgical treatment DEEP<br />

BRAIN STIMULATION (DBS) as a treatment for Parkinson’s<br />

disease that no longer responds to medications.<br />

In DBS, the neurosurgeon implants an<br />

electrode deep into the BRAIN near the thalamus (a<br />

structure with an integral role in movement <strong>and</strong><br />

motor function). The electrodes connect to a pulse<br />

generator, similar in concept to a HEART PACEMAKER,<br />

implanted in a small pocket <strong>of</strong> tissue. The neurologist<br />

programs the pulse generator to deliver regular<br />

electrical impulses that subdue dyskinesias,<br />

rigidity, <strong>and</strong> tremors. DBS can provide relief from<br />

symptoms for a year or two with reprogramming<br />

to adjust the intervals <strong>and</strong> intensity <strong>of</strong> the electrical<br />

impulses.<br />

Parkinson’s disease typically progresses over<br />

several decades. With early treatment many people<br />

can remain symptom free for years. As the<br />

number <strong>of</strong> dopamine-producing cells in the brain<br />

continues to decline, however, medications to<br />

treat Parkinson’s disease become less effective <strong>and</strong><br />

eventually do not work at all. Though Parkinson’s<br />

disease continues to progress, it is not fatal for<br />

most people when the age <strong>of</strong> onset is 60 or later.<br />

Risk Factors <strong>and</strong> Preventive Measures<br />

Researchers do not know what causes Parkinson’s<br />

disease, though it does appear to run in some families.<br />

The most significant risk factor for Parkinson’s<br />

disease is advancing age, as neurologists<br />

diagnose the condition most frequently in people<br />

who are age 60 or older. Researchers believe most<br />

early-onset Parkinson’s disease, which <strong>of</strong>ten<br />

begins in the 30s or 40s, is genetic. There are no<br />

measures known to prevent Parkinson’s disease.<br />

See also AGING, NEUROLOGIC CHANGES THAT OCCUR<br />

WITH; ALZHEIMER’S DISEASE; DEMENTIA; HUNTINGTON’S<br />

DISEASE; PALLIDOTOMY; THALAMOTOMY; TREMOR DISOR-<br />

DERS.<br />

peripheral nerves The nerves that branch from<br />

the CENTRAL NERVOUS SYSTEM to serve the body. The<br />

primary peripheral nerves are the CRANIAL NERVES<br />

<strong>and</strong> the SPINAL NERVES, which branch into smaller<br />

<strong>and</strong> numerous nerves that extend to all parts <strong>of</strong><br />

the body. The peripheral nerves may be visible to<br />

the unaided EYE, as are the cranial nerves <strong>and</strong> the<br />

spinal nerves, or microscopic, as are the tiny<br />

nerves that serve areas such as the fingertips. Sensory<br />

nerves carry signals to the BRAIN <strong>and</strong> motor<br />

nerves carry signals to the body. Some nerves<br />

have both functions.<br />

For further discussion <strong>of</strong> the peripheral nerves<br />

within the context <strong>of</strong> the structures <strong>and</strong> functions<br />

<strong>of</strong> the nervous system, please see the overview<br />

section “The Nervous System.”<br />

See also SPINAL CORD.<br />

peripheral nervous system The CRANIAL NERVES,<br />

SPINAL NERVES, <strong>and</strong> their extensions. The peripheral<br />

nervous system has two major subdivisions: the

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!